Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure
NCT02242331
·
clinicaltrials.gov ↗
COMPLETED
Status
19805
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Micardis®
Sponsor
Boehringer Ingelheim